P862 Clinical benefit potentially evident with...

Journal for ImmunoTherapy of Cancer 2020 / 04 Vol. 8; Iss. Suppl 1

P862 Clinical benefit potentially evident with immunopharmacodynamic responses in prior-checkpoint failed metastatic melanoma patients treated with imprime PGG and pembrolizumab

Chan, Anissa, Bose, Nandita, Bose, Nandita, Ottoson, Nadine, Qiu, Xiaohong, Harrison, Ben, Walsh, Richard, Mattson, Paulette, Gargano, Michele, Cox, Joanna, Chisamore, Michael, Uhlik, Mark, Graff, Jer
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
8
Journal:
Journal for ImmunoTherapy of Cancer
DOI:
10.1136/lba2019.15
Date:
April, 2020
File:
PDF, 47 KB
2020
Conversion to is in progress
Conversion to is failed